The ZRT Laboratory Blog

The ZRT Blog is an extensive resource for patients and health care providers searching for health and hormone testing information. Here, you can read about ZRT’s cutting edge research, advances in testing, wellness advice, and health industry highlights.

On Prostate Cancer Prevention – Identifying Areas of Susceptibility

Posted by Dr. Allison Smith on Friday, 24 June

ThinkstockPhotos-135384606-172098-edited.jpg

In our current medical paradigm, screening for cancer is considered a preventive measure by virtue of providing an earlier diagnosis. Getting an early jump on a disease process like cancer makes treatment exponentially easier and outcomes generally better. Under the current guidelines, that early jump on prostate cancer starts at age 55 for men at low to moderate risk and 40-45 for men at high risk. It takes years for cancer to grow to a detectable point after the tumor's initial induction from a normal cell to a cancerous one. There's been a lot of research done to determine what those inducers are and how they work. Three of these inducers are simple to test for and completely modifiable with treatment and/or avoidance:

  • Bisphenol A
  • Arsenic
  • Catechol estrogens

Read More